pylonephitis - Nursing Case Study

Pathophysiology

• Primary mechanism: Pyelonephritis typically begins with a bacterial infection ascending from the lower urinary tract. Escherichia coli, a common uropathogen, can invade the urethra and bladder, eventually reaching the renal pelvis and parenchyma, leading to inflammation.

• Secondary mechanism: The immune response to infection causes increased white blood cell activity, leading to further inflammation and potential tissue damage in the renal interstitium. This response, while targeting bacteria, can compromise renal function due to swelling and obstruction of renal tubules.

• Key complication: If left untreated, pyelonephritis can progress to chronic kidney damage with scarring, potentially leading to impaired renal function, hypertension, or even renal failure, emphasizing the need for timely diagnosis and treatment.

Patient Profile

Demographics:

32-year-old female, nurse

History:

• Key past medical history: Recurrent urinary tract infections, hypertension

• Current medications: Lisinopril 10 mg daily, Trimethoprim-sulfamethoxazole (recently started for UTI)

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Flank pain and fever

• Key symptoms: Severe left-sided flank pain, nausea, vomiting, chills, dysuria, increased urinary frequency

• Vital signs: Temperature 101.8°F (38.8°C), heart rate 105 bpm, blood pressure 145/92 mmHg, respiratory rate 20 breaths per minute

Section 1

As the case unfolds, the patient's condition begins to show signs of moderate complications. During the initial assessment, further examination reveals a slight increase in the patient's blood pressure to 150/95 mmHg, potentially indicative of worsening renal involvement. The patient also reports increased nausea and a persistent headache, raising concerns of systemic involvement. Physical examination highlights costovertebral angle tenderness on the left side, confirming the suspicion of pyelonephritis. The nurse notes the patient appears pale and mildly diaphoretic, suggesting a possible systemic inflammatory response.

Laboratory results return, showing a marked leukocytosis with a white blood cell count of 16,000/mm³, and a C-reactive protein level significantly elevated at 12 mg/L, further indicating acute inflammation. Urinalysis reveals significant pyuria and bacteriuria, with Escherichia coli isolated on urine culture, consistent with the suspected pathogen. Additionally, serum creatinine is slightly elevated at 1.5 mg/dL, hinting at early renal impairment. These findings suggest the need for prompt escalation in antimicrobial therapy and potential adjustment of the current treatment regimen.

Considering the patient's history of hypertension and current elevation in blood pressure, the clinical team recognizes the importance of closely monitoring renal function and blood pressure to prevent further complications. The decision is made to adjust the patient's antihypertensive medication, given the renal involvement, and to initiate intravenous fluids to manage dehydration and support renal perfusion. The healthcare team must now evaluate the patient's response to these interventions, with an emphasis on preventing progression to chronic renal damage and ensuring effective management of the infection and blood pressure.

Section 2

As the healthcare team closely monitors the patient’s response to the interventions, a change in the patient's status becomes evident. Within 24 hours of initiating the adjusted treatment regimen, the patient's blood pressure begins to stabilize, now reading at 140/90 mmHg. However, the patient reports experiencing increased fatigue and a noticeable decrease in urine output, which prompts immediate concern regarding renal function. The nursing staff observes that the patient's pallor persists, and diaphoresis is still present, albeit less pronounced.

A repeat set of laboratory tests is ordered to assess the current state of the patient's renal and systemic condition. The results indicate that the serum creatinine has increased to 1.8 mg/dL, suggesting a worsening of renal impairment. Additionally, the white blood cell count has elevated slightly to 17,000/mm³, indicating an ongoing inflammatory process, while the C-reactive protein level has decreased to 10 mg/L, potentially reflecting a mild reduction in acute inflammation following the initiation of antimicrobial therapy. Despite these interventions, the persistent oliguria and renal function markers necessitate further evaluation and possible adjustment of therapeutic strategies.

The clinical team deliberates over these findings, recognizing the risk of acute kidney injury progressing to chronic complications. They decide to increase the fluid rate cautiously and consider the introduction of a nephroprotective agent to mitigate further renal damage. The team also discusses the possibility of consulting nephrology for specialized input on managing this complex case. The priority remains to stabilize the patient's renal function while effectively treating the underlying infection, with continuous reassessment to guide further interventions. The patient's journey now hinges on the effective balance between infection control and renal support, with the team remaining vigilant for any signs of hemodynamic instability or further systemic involvement.

Section 3

As the healthcare team continues to address the patient's condition, a new complication arises, marked by the development of peripheral edema and mild pulmonary congestion, as detected through auscultation. The patient's respiratory rate has increased to 24 breaths per minute, and slight crackles have been noted in the lower lung fields, suggesting fluid overload potentially linked to the increased fluid administration. The heart rate remains elevated at 102 beats per minute, while the blood pressure has slightly decreased to 135/85 mmHg. These findings prompt an urgent reassessment of the fluid management strategy to prevent further cardiovascular compromise.

A repeat renal panel shows a further rise in serum creatinine to 2.1 mg/dL, confirming deteriorating renal function. Concurrently, the patient's urine output has diminished to less than 400 mL in 24 hours, reinforcing concerns about acute kidney injury. The decision to introduce a nephroprotective agent is expedited, and the team opts to initiate low-dose furosemide to manage fluid overload while potentially promoting diuresis. In light of these developments, the team consults with nephrology to refine the treatment plan, aiming to protect renal function without exacerbating fluid imbalance.

These changes underscore the precarious balance required in managing this patient's condition. The clinical team remains vigilant, recognizing the importance of frequent monitoring to detect any further decline in respiratory or renal function. The integration of nephrology into the care team opens avenues for specialized interventions that may better address the patient's complex needs. The focus remains on stabilizing the patient's overall status, with a keen eye on preventing progression to chronic kidney disease and ensuring effective resolution of the pyelonephritis.

Section 4

Despite the initiation of low-dose furosemide, the patient's condition is not improving as expected. A follow-up assessment reveals that the peripheral edema has not receded and, in fact, seems to have slightly worsened. The patient reports increased difficulty breathing, particularly when lying flat, indicating potential exacerbation of pulmonary congestion. The respiratory rate has edged up to 26 breaths per minute, and oxygen saturation has decreased to 90% on room air. Auscultation reveals more pronounced crackles extending to the mid-lung fields, suggesting a progression of fluid accumulation in the lungs.

Lab results show a concerning trend: serum creatinine has further increased to 2.4 mg/dL, and blood urea nitrogen (BUN) levels have spiked to 35 mg/dL, reinforcing the possibility of worsening acute kidney injury. Despite the administration of furosemide, urine output remains alarmingly low, at approximately 350 mL over the past 24 hours. Electrolyte analysis indicates a mild hyponatremia, with sodium levels dropping to 132 mEq/L, potentially due to fluid overload and dilutional effects. This constellation of findings raises the possibility of furosemide resistance, a complication that warrants immediate attention.

In response to these developments, the clinical team convenes with nephrology to reconsider and refine the treatment strategy. The potential need for renal replacement therapy is discussed, given the patient's limited response to diuretics and deteriorating renal function. Additionally, the team explores the use of alternative diuretics or vasodilators that might better manage both the fluid overload and renal perfusion. Attention is also given to optimizing the patient's oxygenation status, considering supplemental oxygen and positioning strategies to alleviate respiratory distress. The focus remains on balancing fluid management while safeguarding renal function, with an emphasis on preventing further decompensation.

Section 5

Following the nephrology team's recommendations, the patient was started on a low-dose vasodilator to improve renal perfusion and potentially enhance the diuretic response. The team also initiated supplemental oxygen therapy at 2 liters per minute via nasal cannula, aiming to address the hypoxemia and alleviate respiratory distress. The patient was repositioned with the head of the bed elevated to 45 degrees to promote better lung expansion and ease breathing. Despite these interventions, the patient's condition has taken a concerning turn.

Over the next 12 hours, the patient's respiratory status remains tenuous. The respiratory rate climbs to 28 breaths per minute, with oxygen saturation hovering around 88% despite supplemental oxygen. Auscultation now reveals diffuse crackles throughout both lung fields, and the patient exhibits increased work of breathing with the use of accessory muscles. The patient's blood pressure has fallen to 100/60 mmHg, raising concerns about adequate organ perfusion, particularly in the context of renal compromise.

New laboratory results are alarming: serum creatinine has escalated to 2.8 mg/dL, and BUN has surged to 40 mg/dL, indicating a continued decline in renal function. Despite attempts to adjust the diuretic regimen, urine output remains critically low at 250 mL over the past 24 hours. The electrolytes reveal worsening hyponatremia with sodium levels now at 130 mEq/L. This evolving scenario suggests the emergence of acute decompensated heart failure, compounded by diuretic resistance and progressive renal impairment. The clinical team is now faced with the urgent need to reassess the treatment approach, considering the potential initiation of renal replacement therapy to manage fluid overload and prevent further deterioration.